Pakianathan Deepika
SEC-identified person · CIK 1270734 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Theravance Biopharma, Inc. tbph | Director | filed 2020 - 2026 |
| Karyopharm Therapeutics Inc. KPTI | Director | filed 2013 - 2026 |
| Mereo Biopharma Group plc MREO | Director | filed 2024 - 2026 |
| Calithera Biosciences, Inc. CALA | Director | filed 2014 - 2023 |
| Pardes Biosciences, INC. PRDS | Director | filed 2021 - 2021 |
| Gemini Therapeutics, Inc. /DE IRON | Director | filed 2020 - 2020 |
| Oncomed Pharmaceuticals Inc OMED | Director | filed 2013 - 2019 |
| Alder Biopharmaceuticals INC ALDR | Director | filed 2014 - 2018 |
| Alexza Pharmaceuticals Inc. ALXA | Director | filed 2006 - 2016 |
| Senseonics Holdings, Inc. SENS | Officer | filed 2016 - 2016 |
| Trivascular Technologies, Inc. TRIV | Officer | filed 2014 - 2016 |
| Tandem Diabetes Care INC TNDM | Officer | filed 2013 - 2013 |
| Trans1 INC [BAXS] | Officer | filed 2009 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.